DE LUCA, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
EU - Europa 174.040
NA - Nord America 8.717
AS - Asia 4.091
SA - Sud America 693
Continente sconosciuto - Info sul continente non disponibili 395
AF - Africa 118
OC - Oceania 12
Totale 188.066
Nazione #
IT - Italia 171.575
US - Stati Uniti d'America 8.559
SG - Singapore 1.599
CN - Cina 1.330
BR - Brasile 547
UA - Ucraina 463
SE - Svezia 460
VN - Vietnam 393
DE - Germania 362
FI - Finlandia 248
NL - Olanda 235
GB - Regno Unito 204
FR - Francia 195
HK - Hong Kong 159
IN - India 115
BD - Bangladesh 99
CA - Canada 81
KR - Corea 79
AR - Argentina 50
JP - Giappone 47
PL - Polonia 44
RU - Federazione Russa 39
ES - Italia 36
MX - Messico 36
IQ - Iraq 34
MA - Marocco 31
ZA - Sudafrica 30
TR - Turchia 27
CH - Svizzera 25
PK - Pakistan 25
AT - Austria 24
BE - Belgio 23
ID - Indonesia 23
CO - Colombia 21
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
EC - Ecuador 17
UZ - Uzbekistan 16
VE - Venezuela 16
CL - Cile 15
IE - Irlanda 15
KE - Kenya 14
JM - Giamaica 13
AU - Australia 12
PH - Filippine 12
TW - Taiwan 12
IL - Israele 11
DZ - Algeria 10
EG - Egitto 10
MY - Malesia 10
IR - Iran 9
PY - Paraguay 9
RO - Romania 9
JO - Giordania 8
LT - Lituania 8
PT - Portogallo 8
TN - Tunisia 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EU - Europa 7
KZ - Kazakistan 7
PE - Perù 7
RS - Serbia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HU - Ungheria 6
LV - Lettonia 6
CR - Costa Rica 5
CY - Cipro 5
KG - Kirghizistan 5
LB - Libano 5
PA - Panama 5
AM - Armenia 4
EE - Estonia 4
NP - Nepal 4
PS - Palestinian Territory 4
SN - Senegal 4
BY - Bielorussia 3
GT - Guatemala 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
ET - Etiopia 2
HN - Honduras 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
NO - Norvegia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
Totale 187.662
Città #
Cagliari 166.291
Uta 3.503
Ashburn 857
Singapore 812
Fairfield 699
San Jose 523
Woodbridge 489
Dallas 429
Chandler 424
Houston 345
Boardman 329
Beijing 288
Nyköping 288
Ann Arbor 266
Wilmington 263
Jacksonville 253
Dearborn 242
Seattle 223
Cambridge 220
Council Bluffs 176
Los Angeles 170
Helsinki 162
Milan 162
Santa Clara 147
Hong Kong 142
The Dalles 134
New York 130
Ho Chi Minh City 128
Shanghai 101
Nanjing 99
Lauterbourg 94
Rome 93
Hefei 91
Boston 90
Hanoi 77
Seoul 70
Buffalo 68
Munich 66
Orem 63
Frankfurt am Main 51
São Paulo 48
Dong Ket 44
Guangzhou 42
Atlanta 36
Toronto 35
Tokyo 33
Chennai 32
Chicago 30
Florence 30
Nanchang 30
San Diego 30
London 29
Phoenix 29
San Francisco 26
Changsha 25
Shenyang 25
Brooklyn 24
Columbus 24
Hebei 23
Jiaxing 23
Montreal 23
Redwood City 23
Casablanca 22
Tianjin 22
Norwalk 21
Nuremberg 21
Amsterdam 20
Warsaw 20
Bologna 19
Denver 19
Reggio Emilia 19
Verona 19
Washington 19
Redondo Beach 18
Mountain View 16
Naples 16
Orange 16
Sassari 16
Stockholm 16
Villafranca di Verona 16
Wuhan 16
Belo Horizonte 15
Da Nang 15
Jinan 15
Mexico City 15
Paris 15
Turin 15
Brasília 14
Johannesburg 14
Kunming 14
San Mateo 14
Vienna 14
Zhengzhou 14
Brno 13
Brussels 13
Dublin 13
Düsseldorf 13
Manchester 13
Tashkent 13
Hangzhou 12
Totale 180.337
Nome #
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.381
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.164
Caffeine and the brain: an overview 3.742
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.623
Dopamine restores limbic memory loss, dendritic spine structure, and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats 3.366
Endocannabinoid 2-arachidonoylglycerol self-administration by Sprague-Dawley rats and stimulation of in vivo dopamine transmission in the nucleus accumbens shell 3.277
Metronidazole prodrugs: Synthesis, physicochemical properties, stability, and ex vivo release studies 3.270
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.177
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 3.023
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics 2.948
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.792
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. 2.727
LC-MS-MS determination of rotenone, deguelin, and rotenolone in human serum 2.726
Role of dopamine D(1) receptors in caffeine-mediated ERK phosphorylation in the rat brain 2.707
Serotonergic signaling controls input-specific synaptic plasticity at striatal circuits 2.707
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: jwh-018 2.652
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.635
Loren Parsons' contribution to addiction neurobiology 2.568
Cannabis; epidemiological, neurobiological and psychopathological issues: an update 2.511
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.473
DOPAMINE MICRODIALYSIS IN THEACCUMBENS SHELL/COREAND PREFRONTAL COTEX AFTER ACUTE ANTIPSYCHOTICS 2.420
OX26 MAB IMMUNOLIPOSOMES FOR THE DELIVERY OF SENKTIDE TO THE BRAIN 2.396
Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli 2.354
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 2.334
Cannabinoidi sintetici 2.0: ecco cosa si cela all’interno delle spice drugs 2.331
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia 2.322
5HT/DA system interactions in the reinforcing properties of psychostimulants: role of 5-HT6 receptors 2.293
Sales and advertising channels of new psychoactive substances (NPS): Internet, social networks, and smartphone apps 2.292
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.263
Cannabinoids and drug addiction 2.252
Neuropharmacology of New psychoactive substances (NPS): Focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants 2.204
null 2.160
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.131
Influence of morphine sensitization on the responsiveness of mesolimbic and mesocortical dopamine transmission to appetitive and aversive gustatory stimuli 2.103
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.060
Is there a teratogenicity risk associated with cannabis and synthetic cannabimimetics' ('Spice') intake? 2.053
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 2.030
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.021
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 1.985
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.952
Erratum to: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (Nature Communications, (2018), 9, 1, (2265), 10.1038/s41467-018-04711-w) 1.872
4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study 1.860
Responsiveness of nucleus accumbens and prefrontal cortex dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.837
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.834
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.828
Studio degli effetti acuti e cronici e delle proprietà d'abuso del cannabinoide sintetico JWH-018: Un approccio multidisciplinare 1.812
Brain-wide mapping of endogenous serotonergic transmission via chemogenetic fMRI 1.764
Effect of mPFC 6-OHDA lesions in the NAc Shell DA response to appetitive stimuli 1.756
Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences 1.744
Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice 1.744
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48: Behavioral, neurochemical, and dopamine transporter scan imaging studies in mice 1.726
Behavioural and neurochemical rewarding properties of the endocannabinoid 2-arachidonylglycerol 1.719
Effect of medial prefrontal cortex 6-hydroxy-dopamine on the nucleus accumbens dopamine responsiveness to appetitive stimuli 1.718
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 1.709
Habituation of the responsiveness of mesolimbic and mesocortical dopamine transmission to taste stimuli 1.624
Cannabis come sostanza d'abuso 1.611
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.600
Interaction between 5-HT and DA in relation to the treatment of psychostimulant dependence 1.586
Possible role of 5-HT6 receptors in addictions - Possibile ruolo dei recettori 5-HT6 nelle dipendenze 1.577
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.575
Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue? 1.535
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.526
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 1.432
JWH-018: a cannabinoid compound of Spice drugs stimulates dopamine transmission in the nucleus accumbens shell 1.406
Pharmacological and behavioral effects of the synthetic cannabinoid akb48 in rats 1.383
Taste novelty and dopamine in Food Neophobia Behavioral and Biological Influences 1.368
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment 1.351
Strategies of intervention to limit the novel synthetic opioids (NSO) escalation in Europe 1.322
Typical and atypical antipsychotics: effects on motor behavior and differential responsiveness of shell/core/prefrontal cortex dopamine transmission 1.317
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.271
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.249
Caffeine and accumbens shell dopamine 1.243
Editorial: Deconstructing the influence of genetic and age vulnerability to psychiatric disorders 1.243
Activation of PPAR gamma by the anti-diabetic agent pioglitazone reduces opioid reinforcement and opioid- induced activation of the mesolimbic dopamine system 1.221
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.205
Caffeine and Accumbens shell dopamine 1.195
Responsiveness of n. accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.133
Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus 1.106
Responsiveness of N. Accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.099
Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex 1.068
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 1.056
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.055
BEHAVIORAL AND BIOCHEMICAL CHARACTERIZATION OF THE ST1936, A NEW 5-HT6 AGONIST 1.048
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.048
Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats 1.047
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.040
New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT 2 receptors in pharmacological and behavioral effects in the rat 1.011
Differential effects of natural and pharmacological rewards on dopamine transmission in the nucleus accumbens shell and core and in the prefrontal cortex 1.001
Responsiveness of mesolimbic and mesocortical dopamine transmission to bitter/aversive and sweet/palatable gustatory stimuli in fed ad libitum rats. 980
Differential responsiveness of shell/core/prefrontal dopamine transmission to taste stimuli 948
Dopamine Transmission and aversive motivation 906
Differential effect of morphine-conditioned and food-conditioned stimuli on dopamine release in the nucleus accumbens shell and core and in the prefrontal cortex 899
Role of metabolism in rotenone neurotoxicity 769
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 756
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 722
Characterization of the in vivo efficacy on dopaminergic and noradrenergic neurotransmission of a novel NK3 receptor antagonist: RO5313520. 710
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 702
Dopamine and drug addiction: the nucleus accumbens shell connection 701
In silico characterization of ligand–receptor interactions for U-47700, N,N-didesmethyl-U-47700, U-50488 at mu- and kappa-opioid receptors 656
METRONIDAZOLE TWO AMIDE PRODRUGS: SYNTHESIS, PSYCHOCHEMICAL PROPERTIES, STABILITY AND EX VIVO RELEASE STUDIES 654
Totale 183.303
Categoria #
all - tutte 234.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.080 0 570 506 893 752 485 452 601 951 1.128 933 809
2022/202314.739 1.263 1.932 1.861 1.010 876 1.788 836 1.078 1.001 990 1.417 687
2023/202415.805 683 655 561 860 1.404 2.170 2.365 2.183 765 1.009 1.597 1.553
2024/202521.925 3.522 4.047 4.220 2.877 2.073 1.476 2.037 206 381 312 362 412
2025/20269.402 623 501 946 793 727 609 1.604 518 598 1.721 445 317
2026/2027936 461 475 0 0 0 0 0 0 0 0 0 0
Totale 188.066